Evaluation of Human Platelet Lysate as an Alternative to Fetal Bovine Serum for Potential Clinical Applications of Stem Cells from Human Exfoliated Deciduous Teeth

Bibliographic Details
Title: Evaluation of Human Platelet Lysate as an Alternative to Fetal Bovine Serum for Potential Clinical Applications of Stem Cells from Human Exfoliated Deciduous Teeth
Authors: Ji-Young Yoon, Huong Thu Vu, Jun Hee Lee, Ji-Sun Shin, Hae-Won Kim, Hae-Hyoung Lee, Jong-Bin Kim, Jung-Hwan Lee
Source: Cells, Vol 13, Iss 10, p 847 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Cytology
Subject Terms: stem cells derived from human exfoliated deciduous teeth, human dental pulp stem cells, human platelet lysate, SHED, DPSC, hPL, Cytology, QH573-671
More Details: In recent years, there has been a surge in demand for and research focus on cell therapy, driven by the tissue-regenerative and disease-treating potentials of stem cells. Among the candidates, dental pulp stem cells (DPSCs) or human exfoliated deciduous teeth (SHED) have garnered significant attention due to their easy accessibility (non-invasive), multi-lineage differentiation capability (especially neurogenesis), and low immunogenicity. Utilizing these stem cells for clinical purposes requires careful culture techniques such as excluding animal-derived supplements. Human platelet lysate (hPL) has emerged as a safer alternative to fetal bovine serum (FBS) for cell culture. In our study, we assessed the impact of hPL as a growth factor supplement for culture medium, also conducting a characterization of SHED cultured in hPL-supplemented medium (hPL-SHED). The results showed that hPL has effects in enhancing cell proliferation and migration and increasing cell survivability in oxidative stress conditions induced by H2O2. The morphology of hPL-SHED exhibited reduced size and elongation, with a differentiation capacity comparable to or even exceeding that of SHED cultured in a medium supplemented with fetal bovine serum (FBS-SHED). Moreover, no evidence of chromosome abnormalities or tumor formation was detected. In conclusion, hPL-SHED emerges as a promising candidate for cell therapy, exhibiting considerable potential for clinical investigation.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2073-4409
Relation: https://www.mdpi.com/2073-4409/13/10/847; https://doaj.org/toc/2073-4409
DOI: 10.3390/cells13100847
Access URL: https://doaj.org/article/50be2cce333e445b947bc037a17a73c5
Accession Number: edsdoj.50be2cce333e445b947bc037a17a73c5
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20734409
DOI:10.3390/cells13100847
Published in:Cells
Language:English